Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. DEF 14A Proxy Proxy Statement
  4. DEF 14A Proxy Proxy Statement
  5. DEF 14A Proxy Proxy Statement
  6. DEF 14A Proxy Proxy Statement
  7. DEF 14A Proxy Proxy Statement
  8. DEF 14A Proxy Proxy Statement
  9. DEF 14A Proxy Proxy Statement
  10. DEF 14A Proxy Proxy Statement
  11. DEF 14A Proxy Proxy Statement
  12. DEF 14A Proxy Proxy Statement
  13. DEF 14A Proxy Proxy Statement
  14. DEF 14A Proxy Proxy Statement
  15. DEF 14A Proxy Proxy Statement
  16. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 16 filings